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Abstract.  A cell-free assay has been developed for the 
delivery of influenza virus neuraminidase to the 
plasma membrane. Two types of postnuclear superna- 
tant, which acted as donor and acceptor of the en- 
zyme, were prepared from baby hamster kidney cells. 
Donor preparations were obtained from cells infected 
with influenza virus and containing neuraminidase en 
route to the plasma membrane. Acceptor preparations 
were obtained from cells containing, bound to their 
plasma membranes, Semliki Forest virus with enve- 
lope glycoproteins bearing [3H]N-acetylneuraminic 
acid. Fusion between vesicles from these two prepara- 
tions permits access of the enzyme to its substrate, 
which results in the release of free [3H]N-acetylneur- 
aminic acid. This release was detected through the 
transfer of radioactivity from a trichloroacetic acid- 
insoluble to a trichloroacetic acid-soluble fraction. An 
ATP-dependent component of release was found, 
which appears to be a consequence of vesicle fusion. 
This component was enhanced when the donor was 
prepared from cells in which the enzyme had been 
concentrated in a compartment between the Golgi 
complex and the plasma membrane, which indicates 
that a specific  exocytic fusion event has been recon- 
stituted. The extent of fusion is greatly reduced by 
pre-treatment of donor and acceptor preparations with 
trypsin, which points to the involvement of proteins in 
the fusion reaction. 
I 
r~  eukaryotic  cells  transport  of proteins  between  or- 
ganelles is believed to be mediated by vesicles that bud 
off one  compartment  and  fuse  with another  (Palade, 
1975). To avoid randomization of membrane components as 
a  consequence  of this  extensive vesicular  traffic, vesicles 
must be able to select and package proteins that are to be 
transported out of an organelle, leaving behind resident pro- 
teins, and then diffuse towards and fuse specifically with the 
target organelle. The elucidation of the molecular details of 
this protein transport system will require the reconstitution 
of its various components in cell-free preparations. This ap- 
proach has already yielded important information about the 
transport of membrane proteins through the Golgi complex 
(Balch et al., 1984a, b; Braell et al., 1984). In this paper we 
describe a cell-free assay for the final step in the intracellular 
transport pathway of a newly synthesized viral glycoprotein, 
that is, its delivery into the plasma membrane. 
In cells infected with influenza virus,  the viral envelope 
glycoproteins, haemagglutinin and neuraminidase,  are syn- 
thesized in large amounts  (Rodriguez-Boulan and Pender- 
gast, 1980; Fuller et al., 1985) and are transported from their 
site of synthesis in the endoplasmic reticulum to the plasma 
membrane via the Golgi complex (Rodriguez-Boulan et al., 
1984; Rindler et al.,  1984; Edwardson,  1984). They have, 
therefore, been used extensively as model plasma membrane 
proteins. We decided to exploit the enzyme activity of neur- 
aminidase in designing a cell-free assay for fusion of post- 
Golgi vesicles with the plasma membrane. 
Materials and Methods 
Cells and Virus 
Baby hamster kidney (BHK-21)  cells were grown as monolayers in Glas- 
gow's  minimum  essential  medium  (GMEM) 1 supplemented with  10% 
newborn calf serum, 10 % tryptose phosphate broth, and 160 t~g/ml gentami- 
cin. All cells, medium, and supplements were supplied by Flow Laborato- 
ries, Rickmansworth, Herts. 
The WSN (H1N1) strain of influenza virus, initially obtained from Dr. 
S. C. Inglis (Department of Pathology, University of Cambridge, UK), was 
grown in fertile hens' eggs, purified by centrifugation on a continuous su- 
crose density gradient (15-60% wt/vol in 50 mM Tris-HCl, pH 7.4,  100 mM 
NaC1) for 2 h at 100,000 g and assayed by plaquing on Madin-Darby canine 
kidney (MDCK)  cell monolayers. Stocks of virus were stored in liquid 
nitrogen. 
Semliki Forest virus (SFV), initially obtained from Dr. T. R.  Hesketh 
(Department of Biochemistry, University of Cambridge, UK), was grown 
on BHK-21 cells. Cells (10  s at 50% confluence on 5  x  14-cm diam tissue 
culture dishes) were washed twice with Eagle's minimum essential medium 
containing 0.2 % (wt/vol) bovine serum albumin (BSA; Sigma, Poole, Dor- 
set) and 20 mM Hepes, pH 6.8, and infected with 0.01 plaque-forming units 
(pfu) of SFV/cell in the same medium for 1 h at 37°C.  The medium was 
then replaced with 50 inl complete GMEM. After 15 h at 37°C the medium 
was harvested and centrifuged at 5,000 g for 30 min to sediment cell debris. 
SFV was sedimented by centrifugation at 60,000  g  for 2.5 h and purified 
by centrifugation for 2 h at 100,000 g on a gradient consisting of 10-20% 
(wt/vol) sucrose in 50 mM Tris-HCl, pH 7.4,  100 mM NaCl above 25-50% 
1.  Abbreviations used in  this paper:  DD-NANA,  2,3-dehydro-2-desoxy- 
N-acetylneuraminic acid;  GMEM,  Glasgow's modified Eagle's medium; 
NANA, N-acetylneuraminic acid; pill, plaque-forming unit; SFV, Semliki 
Forest virus; STM, sucrose, Tris, magnesium acetate. 
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nitrogen. 
Preparation of pH]SFV 
Preparation of [3H]SFV  was as described above for SFV, except that the 
post-infection maintenance medium contained 5 mCi [3H]N-acetyl-o-man- 
nosamine (30 Ci/mmol; New England Nuclear, Stevenage, Herts). The en- 
velope glycoproteins of shed virions consequently contained [3H]N-acetyl- 
neurarninic acid ([3H]NANA)  (Monaco and Robbins, 1973). 
Preparation of  Donor Postnuclear  Supernatant 
BHK  cells  (10  s  at  near-confluence on  3  x  14-cm  diam tissue  culture 
dishes) were washed twice with 30 ml GMEM containing 0.2%  (wt/vol) 
BSA and infected with 10 pfu influenza virus/cell in the same medium for 
1 h at 37°C.  The medium was replaced with GMEM containing 2% new- 
born calf serum. After a further 4 h at 37°C, the cells were either harvested 
at once or incubated for a further 1 h at 20°C. The medium was discarded 
and the cells were washed twice with 30 ml infection medium without virus 
and twice with 30 ml STM buffer (250 mM sucrose, 10 mM Tris-HC1,  pH 
7.5, 1 mM magnesium acetate). The dishes were drained and the cells were 
scraped off using a rubber scraper. The cell suspension (volume '~2 nil) was 
homogenized in a Dounce homogenizer, and a postnuclear supernatant was 
prepared by centrifugation at 500 g  for 5 min. Donor preparations were 
stored in 250 gl samples in liquid nitrogen. 
Preparation of Acceptor Postnuclear Supernatant 
BHK  cells  (10  s at  near-confluence on  3  x  14-cm  diam  tissue  culture 
dishes) were cooled to 4°C and washed twice at this temperature with 30 ml 
GMEM, pH 6.8, containing 0.2% (wt/vol) BSA. [3H]SFV (,',,2  x  106 dis- 
integrations per minute  [dpm])  was then added  in  15  mi  of the above 
medium, and the cells were rocked gently for 2  h  at 4°C.  The binding 
medium was removed and the cells were washed twice with 30 mi of the 
above medium and twice with 30 ml of STM buffer, each time at 4°C. The 
dishes were then drained and the cells were scraped off, homogenized, and 
centrifuged as described above. A typical preparation contained 5  x  105 
dpm.  Acceptor preparations  were  stored  in  250-gl  samples  in  liquid 
nitrogen. 
Determination of  Acceptor Latency 
Samples of [3H]SFV  (4,000-8,000  dpm) or acceptor preparation (50 gl) 
were incubated at 37°C for 2 h with either neuraminidase from Clostridium 
perfringens  (Sigma Type V; 400  mU/ml),  or  influenza virus  (4  x  107 
pfu/ml) in 250 gl of STM buffer containing 25 mM potassium chloride, 25 
mM Hepes-KOH, pH 7.0, 1.5 mM magnesium acetate, and 1 mM dithio- 
threitol (Sigma). In some cases incubation mixes contained 0.1% (wt/vol) 
Triton X-100. At the end of the incubation the tubes were cooled on ice and 
5 I~1 10% (wt/vol) Triton X-100 in 250 mM K2EDTA, pH 6.9 was added to 
solubilize the membranes. Protein was precipitated by the addition of 250 
~t120% (wt/vol) TCA. After 1 h on ice the tubes were centrifuged for 1 min 
in an Eppendorf  microfuge and the superuatant fluids were removed. Radio- 
activity was counted by liquid scintillation spectrometry using 0.6 % (wt/vol) 
butyl PBD/70% (vol/vol) toluene/30% (vol/vol) Triton X-100 as scintillation 
fluid. All determinations were made in either duplicate or triplicate. 
Cell-free Assay 
For standard assays 50 I.tl of donor preparation was mixed with 50 gl of ac- 
ceptor preparation (>10,000 dpm), 100 ltl of STM buffer, 25 gl of a solution 
containing 250 mM potassium chloride, 250 mM Hepes-KOH, pH 7.0, 15 
mM magnesium acetate and 10 mM dithiothroitol (Sigma), 10 Ixl of 25 mM 
2,3-dehydro-2-desoxy-NANA  (Boehringer Mannheim GmbH, Mannheim, 
FRG), an inhibitor of neuraminidase (Meindl et al., 1974), and either 5 txl 
of an ATP-depleting cocktail (1,250 IU/rni hexokinase [Sigma Type C-300, 
from baker's yeast] in 250 mM glucose) or 7.5  gl of an ATP-generating 
cocktail (2.5 gl 100 mM ATP [Sigma, from equine muscle, disodium salt]), 
2.5 I~1800 mM creatine phosphate (Boehringer Mannheim GmbH), and 2.5 
~tl 700 IU/ml creatine phosphokinase (Sigma Type I, from rabbit muscle). 
The total volume of  the mixture was made up to 250 I~1 with water. The mix- 
ture was incubated at 37*C, usually for 1 h. At the end of the incubation 
the tubes were cooled on ice and processed as above. All determinations 
were made in either duplicate or triplicate. 
Results 
Principle of the Assay 
Fig.  1 illustrates the principle of the cell-free assay.  Two 
types of postnuclear supernatant, which acted as donor and 
acceptor of neuraminidase,  were  prepared  from BHK-21 
cells. Donor preparations were obtained from cells infected 
with influenza virus, and containing neuraminidase en route 
to the plasma membrane.  Acceptor preparations were ob- 
tained from cells containing, bound to their plasma mem- 
branes, SFV with envelope glycoproteins beating [3H]NANA. 
Fusion between vesicles from these two preparations permits 
access of the enzyme to its substrate, which results in release 
of  free  [3H]NANA.  This  release  was  detected  through 
transfer of  radioactivity from a TCA-insoluble to a TCA-solu- 
ble  fraction.  The NANA  analogue 2,3-dehydro-2-desoxy- 
donor vesicle  acceptor vesicle 
fused  vesicle 
influenza 
neuraminidase 
[3HI.SFV 
[3 H] NANA 
Figure 1. Principle of the cell-free assay. Two types of postnuclear 
supernatant, which act as donor and acceptor of neuraminidase, are 
prepared from BHK-21 cells. Donor preparations are obtained from 
cells infected with influenza virus and containing neuraminidase en 
route to the plasma membrane. Acceptor preparations are obtained 
from cells containing, bound to their plasma membranes, SFV with 
envelope glycoproteins bearing [3H]NANA.  Fusion between vesi- 
cles from these two preparations results in access of the enzyme to 
its  substrate  and  release of free [3H]NANA.  This  release is de- 
tected through transfer of radioactivity from a  TCA-insoluble to a 
TCA-soluble  fraction.  Trivial  release of [3H]NANA  as  a  conse- 
quence of contact between vesicles bearing externally exposed en- 
zyme and substrate is minimized by inclusion in the incubation mix 
of DD-NANA, an inhibitor of neuraminidase. Vesicles are shown 
bearing outward-facing "recognition markers" that are presumed to 
mediate the specific fusion reaction. 
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cluded routinely in the assays, to prevent trivial release of 
[3H]NANA consequent on contact between vesicles bearing 
externally exposed enzyme or substrate. 
A similar approach has been used by Davey et al. (1985) 
in the cell-free reconstitution of an endocytic fusion event. 
Characterization  of the Acceptor Preparation 
To permit an estimation of  the efficiency  of any vesicle fusion 
reaction, it was necessary to determine the percentage of the 
[3H]SFV in an acceptor preparation that was located within 
sealed  vesicles,  a  figure  that  we  term  acceptor  latency. 
Latency was determined by comparing the abilities of neur- 
aminidase  to  cleave  [3H]NANA  from [3H]SFV  and  from 
samples  of acceptor  preparation.  Soluble  neuraminidase 
from Clostridium perfringens was used to remove the possi- 
bility that unsealed vesicles, that were nevertheless able to 
exclude influenza virions,  would  give an  artificially high 
value for acceptor latency.  In  a  typical experiment neur- 
aminidase cleaved maximally 79 % of the total radioactivity 
from [3H]SFV and 68 % from a sample of acceptor prepara- 
tion.  It was confirmed by chromatography on Bio-Gel P2 
(Bio-Rad, Watford, Herts; data not shown) that the radioac- 
tivity released was associated with NANA. The percentage 
of the total [3H]SFV in the acceptor preparation that is ex- 
posed to enzyme is,  then,  100  ×  % cleavage from accep- 
tor/% cleavage from [3H]SFV,  which equals  100  x  68/79, 
or 86%. Hence,  14% of the total [3H]SFV in this acceptor 
preparation is protected inside  sealed vesicles. The mean 
latency value (+  SEM) obtained was  16  +  4%  (n  =  12). 
Influenza virion-bound neuraminidase could cleave max- 
imally only 61  +  2% (n =  4) of [3H]NANA from [3H]SFV. 
Since acceptor latency is 16 %, therefore, the maximum pos- 
sible fusion-dependent release of [3H]NANA will be ,o10% 
of the total. 
The observation that soluble neuraminidase, from C. per- 
fringens,  is more effective than virion-bound enzyme sug- 
gests that steric hindrance of both enzyme and substrate is 
occurring.  This idea is supported by the finding that both 
forms of enzyme cleaved off at least 90% of [3H]NANA in 
the presence of the detergent Triton X-100 (0.1% [wt/vol]). 
This effect of Triton X-100 renders it impossible to measure 
latency by comparing the cleavage produced by neurarnini- 
dase in the presence and absence of detergent.  The near- 
complete cleavage produced by influenza neuraminidase in 
Table I. Results from a Typical Cell-free Assay 
Donor 
ATP-dependent  ATP-dependent,  influenza 
Release of  release of  neuraminidase-dependent 
ATP  [3H]NANA (%)  [3H]NANA (%)  release of [3H]NANA (%) 
Blank  -  0.0  +  0.2  - 
+  0.7  +  0.2  0.7  +  0.2  - 
Donor  -  10.8  +  0.3  - 
+  15.3  -t-  0.4  4.5  +  0.4  3.8  +  0.4 
Samples of acceptor preparation were incubated at 37°C for 1 h with samples 
of either blank donor or donor preparations in the presence of either an ATP- 
depleting cocktail (-) or an ATP-generating cocktail (+). Protein was precipi- 
tated  by  the  addition of TCA,  and  the percentage of the total  [3H]NANA 
released into the supernatant  fluid was determined.  Values are means 5: SEM 
of triplicate determinations. All of the ATP-dependent  components  of release 
of [3H]NANA are statistically significant (P <  0.01). 
the presence of Triton X-100 indicates, of course, that the 
specificity of the viral neuraminidase and the glycosylation 
of SFV in BHK-21  cells are complementary. 
The Cell-free Assay 
We expected that the  fusion event in  which  we  were in- 
terested would require energy. Consequently, donor and ac- 
ceptor preparations were incubated together in the absence 
and presence of ATE Table I shows the results obtained in 
a typical experiment. Donor prepared from influenza virus- 
infected cells gave both ATP-dependent and ATP-indepen- 
dent components of release of [3H]NANA.  Blank donor, 
prepared from mock-infected cells, gave a small ATP-depen- 
dent component of release and no ATP-independent compo- 
nent. The ATP-dependent component of release given by the 
blank donor preparation was found to be time-dependent and 
sensitive to heat treatment of the extract (data not shown). 
At present the significance of this component is unclear. 
DD-NANA, an inhibitor of neuraminidase, was included 
routinely in the assays. Any release occurring in the presence 
of DD-NANA should be a consequence of enzyme-substrate 
interaction within a compartment from which the inhibitor 
is excluded, provided that its concentration is sufficient to 
saturate the enzyme. In the absence of DD-NANA, the small 
ATP-dependent component of release  of [3H]NANA  was 
superimposed on a large background release of 30-60 % of 
the total radioactivity, and so was difficult to measure repro- 
ducibly. The ATP-independent release of [3H]NANA given 
by donor preparations appears to be a result of incomplete 
inhibition of externally exposed enzyme by the DD-NANA. 
This component of release increases linearly over the 1-h in- 
cubation period, and its magnitude at the end of this period 
falls progressively as the concentration of DD-NANA is in- 
creased (data not shown). At a concentration of 5 mM DD- 
NANA, the highest that can reasonably be achieved, ATP- 
independent release falls to ,o8%. 
Table H shows the pooled results from ten cell-free assays. 
As can be seen, the ATP-dependent component of release of 
[3H]NANA given by donor preparations is approximately 
fourfold greater than that given by blank donor preparations. 
The ATP-dependent, Influenza 
Neuraminidase-dependent Component of  Release of 
ffH]NANA Is a Consequence of Vesicle Fusion 
The inclusion of the detergent Triton X-100 in the incubation 
mix, at a concentration (0.1% wt/vol) that should lyse vesi- 
cles,  abolished  the  ATP-dependent,  influenza  neuramini- 
dase-dependent component of release of [3H]NANA given 
by donor preparations but did not affect that given by blank 
donor preparations  (Fig.  2).  This result indicates that the 
ATP-dependent,  influenza  neuraminidase-dependent  com- 
ponent of release of [3H]NANA is a consequence of vesicle 
Table II. Pooled Results from Ten Assays 
ATP-dependent,  influenza 
ATP-dependent  release of  neuraminidase-dependent 
Donor  [3H]NANA (%)  release of [3HINANA (%) 
Blank  1.2  +  0.2 
Donor  5.1  +  0.5  3.9  +  0.5 
See footnote  to Table I. 
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Figure 2.  Effect  on ATP-de- 
pendent release  of free  [3H]- 
NANA of the presence of Tri- 
ton  X-100 in  the  incubation 
mix. Incubations were carried 
out as usual  either in the ab- 
sence or the presence of Tri- 
ton X-100 (0.1% wt/vol).  Pro- 
tein  was  precipitated  by  the 
addition  of TCA, and the val- 
ues  of  the  ATP-dependent 
components of release  of free 
[3H]NANA  were  calculated. 
Values are means + SEM from 
five separate  experiments. 
fusion. Further evidence that this is indeed the case was ob- 
tained  from  an  experiment  in  which  the  release  of 
[3H]NANA given by a  standard preparation was compared 
with that given by blank preparations to which enzyme and 
substrate had been added at the start of the incubation (Table 
III).  A  statistically  significant  ATP-dependent,  influenza 
neuraminidase-dependent  component of release  was given 
only by a combination of standard donor and acceptor prepa- 
rations. Hence, enzyme and substrate must be present within 
sealed vesicles. 
7~me-course of the ATP-dependent,  Influenza 
Neuraminidase-dependent  Component of  Release 
of PHINANA 
The  time-course  of  the  ATP-dependent,  influenza  neur- 
aminidase-dependent  component of release  of [3H]NANA 
is shown in Fig.  3.  The time-course has a distinct sigmoid 
shape. This may reflect the need for a finite time for the vesi- 
cle populations to fuse together and deliver enzyme to sub- 
strate.  The relationship between the time-courses of release 
and of vesicle fusion is at present unclear, although the time- 
course of the action of enzyme on substrate clearly contrib- 
utes  significantly. 
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Figure 3. Time-course of the ATP-dependent,  influenza neuramini- 
dase-dependent  component of release  of [3H]NANA.  Samples  of 
acceptor preparation were incubated at 37°C for various times with 
samples of either blank donor or donor preparations  in the presence 
of either an ATP-depleting cocktail or an ATP-generating cocktail. 
Protein was precipitated  by the addition of TCA, and the values for 
the  ATP-dependent,  influenza  neuraminidase-dependent  compo- 
nent of release of free [3H]NANA at the various times were calcu- 
lated.  Values are means +  SEM from four separate  experiments. 
Specificity of the Fusion Reaction 
If the component of release of free  [3H]NANA that  is de- 
pendent on both influenza virus and ATP does indeed repre- 
sent a  membrane fusion event that is normally responsible 
for the delivery  of influenza  neuraminidase  to the plasma 
membrane,  then it should show specificity. In other words, 
only post-Golgi vesicles from the donor preparation should 
fuse with plasma membrane vesicles from the acceptor prep- 
aration.  We set out to establish whether there was any evi- 
dence for this  specificity. 
Since the production of acceptor involves the binding of 
[3H]SFV to BHK-21 cells at 4°C, a temperature at which no 
Table III. Dependence of the Release of Free 13H]NANA on the Position of Enzyme and Substrate Relative to 
Vesicle Membranes 
ATP-dependent,  influenza 
neuraminidase-dependent 
Donor  Acceptor  ATP-dependent  release of [3H]NANA (%)  release of [3H]NANA (%) 
Blank  Acceptor  1.6  +  0.7  - 
Blank +  influenza virus  Acceptor  2.4  +  0.7  0.8  _+  1.0 
Donor  Acceptor  5.9  +  1.2  4.3  ±  1.4 
Blank  Blank +  [3H]SFV  3.0  +  0.9  - 
Blank +  influenza virus  Blank +  [3H]SFV  0.3  +  2.6  -2.7  _  2.8 
Donor  Blank +  [3H]SFV  0.8  _  1.0  -2.2  ___  1.3 
Reactions  were carried out using standard donor and acceptor preparations, and also blank donor preparations to which was added,  at the start of the incubation, 
influenza virus (of neuraminidase activity equal to that of the standard  donor),  and blank acceptor preparations  to which was added [3H]SFV (containing  an equal 
amount of radioactivity to that of the standard  acceptor extract). Samples  were incubated  together in pairs, as shown,  at 37°C for  1 h.  Protein was precipitated 
by the addition of TCA, and the values for ATP-dependent  release of free [3H]NANA given by the various pairs were calculated.  Values  are means  +  SEM of 
triplicate determinations.  Of the ATP-dependent,  influenza neuraminidase-dependent  components  of release of [3H]NANA, only that given by the standard  com- 
bination of donor and acceptor is statistically significant  (P <  0.01). 
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virions in these preparations will be bound exclusively to the 
plasma membrane. However, there is no simple way of ob- 
taining a donor preparation containing influenza neuramini- 
dase exclusively in post-Golgi vesicles. Instead, an attempt 
was made to concentrate neuraminidase in a compartment 
late in the transport pathway. Such a preparation would be 
expected to give an enhanced ATP-dependent release of free 
[3H]NANA for a  given amount of neuraminidase  activity. 
The procedure used to obtain this preparation is based on the 
observation (Matlin and Simons, 1983; Rodriguez-Boulan et 
al., 1984; Fuller et al., 1985; Griffiths et al., 1985) that incu- 
bation of enveloped virus-infected cells at 20°C causes an ar- 
rest in the transport of the viral envelope glycoproteins in a 
reticular, membrane-limited compartment on the trans side 
of the Golgi complex. Specifically, cells were infected with 
influenza virus at 37°C for 5 h and then cooled to 20°C for 
1 h before homogenization. In addition, a donor preparation 
was obtained from ceils to which influenza virus had been 
bound for 2 h at 4°C. This preparation will contain influenza 
neuraminidase bound exclusively to the plasma membrane, 
and would be expected to give little or no ATP-dependent re- 
lease of free [3H]NANA. 
The  neuraminidase  activities  of these  two  new  donor 
preparations,  and  of a  standard  37°C  donor  preparation, 
were determined by measuring the initial rates of release of 
[3H]NANA from [3H]SFV in the presence of 0.2 % (wt/vol) 
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Figure 4. Specificity of the fusion reaction. In addition to the stan- 
dard blank donor and donor preparations, postnuclear supernatants 
were prepared from infected cells that had been incubated at 37°C 
for 5 h and then at 20°C for 1 h, and from cells to which influenza 
virus had been bound for 2 h at 4°C. Samples of the donor prepara- 
tions, containing equal amounts of enzyme activities and with their 
protein concentrations  balanced by the addition of BSA, were in- 
cubated with samples of acceptor preparation  at 37°C for 1 h.  A 
sample of blank donor preparation was also included. Protein was 
precipitated by the addition of TCA, and the ATP-dependent release 
of [3H]NANA was determined.  Values are means of duplicate de- 
terminations  which differed by <10 %. 
Triton X-100. Protein concentrations were determined by the 
method of Bradford (1976).  Samples of these donor prep- 
arations,  containing  equal  amounts  of neuraminidase  ac- 
tivity,  and  with  protein  concentrations  balanced  by  addi- 
tion of BSA, were then subjected to the usual fusion assay. 
The  values  obtained  for  ATP-dependent  release  of  free 
[3H]NANA are shown in Fig.  4.  The release produced by 
the 20°C donor was almost double that given by the 37°C do- 
nor and approximately fivefold greater than that given by the 
plasma membrane donor.  In this particular experiment the 
blank donor gave no ATP-dependent release. Hence, the de- 
gree of release produced depends on the position of neur- 
aminidase within the cell, as would be expected of a specific 
fusion event. There was no correlation between the amount 
of protein  contained  in  the  donor  samples  and  the  ATP- 
dependent  release of [3H]NANA produced.  For example, 
the 37°C donor sample contained 20% more protein than the 
20°C donor sample but had less activity in the assay. Hence, 
the variation in donor activity observed is not simply a con- 
sequence of differences in the amounts of postnuclear super- 
natant  used.  In  addition,  there  was  no  indication  of  a 
position-dependence of the ATP-independent component of 
release (data not shown), a result that would be expected of 
a trivial effect unrelated to fusion. 
EJ~ciency of the Fusion Reaction 
The  ATP-dependent,  influenza  neuraminidase-dependent 
component of release of [3H]NANA produced after a  2-h 
incubation at 37°C amounts to 5.7 % of total (Fig. 3). Given 
that the latent releasable [3H]NANA represents  10%  of to- 
tal, fusion is •57%  efficient at its end-point. Except where 
stated, the results presented in this paper were obtained using 
donor preparations obtained from cells in which intracellular 
transport of neuraminidase was blocked in the trans Golgi 
reticulum by incubation at 20°C for 1 h. As is shown in Fig. 
4,  fusion is less efficient if this procedure is not adopted. 
Fusion Requires Proteins 
It was expected that vesicle fusion would require the pres- 
ence of proteins both on the c2¢toplasmic surface of the vesi- 
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Figure 5.  Trypsin  sensitivity 
of the fusion reaction. Incuba- 
tion mixes were treated  with 
either  trypsin-TPCK  (Sigma 
Type  XIII;  100  p.g/ml)  or 
trypsin-TPCK  plus  soybean 
trypsin inhibitor  (Sigma;  100 
lag/ml) for 1 h at 4°C. Soybean 
trypsin  inhibitor  was  then 
added to trypsin-treated  sam- 
pies, and all samples were in- 
cubated  at  37°C for  1 h  as 
usual.  Protein  was then pre- 
cipitated by addition of TCA, 
and  the  ATP-dependent  re- 
lease  of [3H]NANA was de- 
termined. Values are means + 
SEM of triplicate  determina- 
tions. 
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effect of trypsin treatment of the preparations on the fusion 
reaction was investigated. Mixed donor and acceptor prepa- 
rations were treated with trypsin-TPCK (100 txg/ml) at 4°C 
for 1 h. Soybean trypsin inhibitor (100 Ixg/ml) was then added 
and the preparations were incubated at 37°C for 1 h as usual. 
The results obtained are shown in Fig. 5. Trypsin treatment 
caused an 84 % reduction in the size of the ATP-dependent, 
influenza neuraminidase-dependent component of release of 
[3H]NANA,  which  indicates that proteins are  involved in 
the  fusion reaction.  Since crude postnuclear supernatants 
were used in this experiment, it is not possible at present to 
discriminate between proteins bound to the vesicle mem- 
branes and those free in the cytosol. 
Discussion 
In this paper we describe a cell-free assay for the insertion 
of influenza virus neuraminidase into the plasma membrane 
which exploits the enzyme activity of this glycoprotein. En- 
zyme and substrate (SFV with envelope glycoproteins con- 
raining  [3H]NANA) have been placed in  separate popula- 
tions of vesicles and fusion between the two populations has 
been  monitored  by  the  appearance  of the  product,  free 
[3H]NANA.  The  assay  has  revealed  two  influenza  neur- 
aminidase-dependent components of release of [3H]NANA, 
one ATP-independent and the other ATP-dependent. Only 
the latter component appears to be associated with vesicle fu- 
sion.  Since vesicle-mediated intracellular transport of pro- 
teins is known to be a highly specific, energy-dependent pro- 
cess (Palade, 1975), we are encouraged by our identification 
of a fusion reaction that requires the presence of ATP in the 
incubation mix and that is sensitive to the position of neur- 
aminidase in the cells from which the donor preparation is 
obtained. 
The only information available so far about the donor com- 
partment is that it appears to be situated late in the transport 
pathway of neuraminidase.  Incubation of influenza virus- 
infected cells at 20°C could cause a concentration of neur- 
aminidase  in  genuine vesicles that  are  competent to  fuse 
with the plasma membrane only at 37°C.  Alternatively, the 
homogenization procedure could artificially generate fusion- 
competent vesicles from the budding  reticular network of 
membranes observed on the trans face of the Golgi complex 
in these cells (Griffiths et al.,  1985).  Answers to questions 
such as these must await the further characterization of the 
cell-free vesicle fusion reaction. 
Under the conditions used at present, donor preparations 
cannot bring about the complete release of latent [3H]NANA. 
The most likely explanation of this incomplete release is that 
the amount of neuraminidase present in fusion-competent 
vesicles in a typical donor preparation is limiting.  An in- 
crease in the amount of donor preparation used in the assay 
is unlikely to solve this problem because this will increase 
not only the number of fusion-competent donor vesicles, but 
also the number of competing unlabeled plasma membrane 
target vesicles. What is required is an increase in the percent- 
age of the total neuraminidase that is contained in fusion- 
competent vesicles. Such an increase is apparently produced 
(Fig. 4) by blocking the intracellular transport of newly syn- 
thesized neuraminidase in the trans Golgi reticulum by incu- 
bation of cells at 20°C.  It should be possible to produce a 
further increase by exploiting the observation (Matlin and Si- 
mons,  1983;  Rodriguez-Boulan et al.,  1984;  Fuller et al., 
1985; Griffiths et al.,  1985) that re-warming 20°C-blocked 
cells causes the rapid (5-30 min) appearance of the proteins 
at the cell surface. By choosing the correct time of incubation 
at 37°C a donor preparation further enriched in neuramini- 
dase-containing, fusion-competent vesicles could in princi- 
ple be obtained. At present, we are investigating the efficacy 
of this procedure. 
A problem with the assay reported here is the production 
by blank donor preparations of a significant, and variable, 
ATP-dependent component of release of free [3H]NANA. A 
similar finding has been reported by Davey et al. (1985), who 
suggest that this component is caused by enzymes, other than 
neuraminidases,  released during  the  homogenization.  We 
are attempting to circumvent this problem by reconstituting 
the incubation mix from individual membrane preparations 
supplemented with cytosol preparations. Preliminary experi- 
ments indicate that conditions can be obtained in which all 
of the ATP-dependent component of release depends also on 
the presence of influenza neuraminidase.  The use of mem- 
brane  fractions supplemented  with  cytosol will  eliminate 
some of the problems with experimental design that have 
been encountered using crude postnuclear supernatants. For 
example, in comparisons between the activities of different 
donor preparations, both membrane and cytosol protein con- 
centrations of the preparations should ideally be equalized. 
However, this is impossible when crude postnuclear super- 
natants are used. In addition, the use of fractionated donor 
and acceptor preparations would make possible a more com- 
plete study of the requirements of the vesicle fusion reaction 
for cytosolic components and for proteins expressed on the 
cytoplasmic surfaces of the vesicles. 
An advantage of the use of influenza neuraminidase as a 
model protein in  these  studies  is  the  fact that this  glyco- 
protein  is  known  to  be  delivered  asymmetrically  to  the 
plasma membrane of epithelial cells in culture. For exam- 
ple, in MDCK cell monolayers influenza envelope glycopro- 
teins are delivered almost exclusively to the apical surface, 
whereas vesicular stomatitis virus G is delivered almost ex- 
clusively to the basolateral surface (Rodriguez-Boulan and 
Sabatini,  1978; Rodriguez-Boulan and Pendergast,  1980). It 
has been demonstrated by two different techniques (Rindler 
et al.,  1984; Fuller et al.,  1985) that these proteins reside in 
the same membrane domain until at least the trans cisternae 
of the Golgi complex. This raises the possibility that vesicles 
budding from the trans  Golgi can package separately pro- 
teins destined for the two domains of the plasma membrane 
of the epithelial cell and then fuse specifically with the appro- 
priate domain to deliver their cargo. Using the cell-free assay 
reported here it may be possible to determine whether post- 
Golgi vesicles containing influenza neuraminidase do indeed 
fuse specifically with the apical domain of the plasma mem- 
brane of MDCK cells, and if this is the case to elucidate the 
molecular basis of this specificity. However, it will be neces- 
sary first to devise methods for binding the target substrate, 
[3H]SFV,  separately to both surfaces of MDCK cell mono- 
layers. 
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